Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Silverback Therapeutics Inc (SBTX)

Silverback Therapeutics Inc (SBTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 211,660
  • Shares Outstanding, K 36,058
  • Annual Sales, $ 0 K
  • Annual Income, $ -89,480 K
  • 60-Month Beta 0.60
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.78
Trade SBTX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.42
  • Most Recent Earnings -0.50 on 11/02/22
  • Next Earnings Date 11/09/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 65.33%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.67
  • Growth Rate Est. (year over year) +149,204.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.91 +19.55%
on 10/13/22
6.50 -9.69%
on 10/31/22
+0.62 (+11.81%)
since 10/07/22
3-Month
4.45 +31.91%
on 09/23/22
6.50 -9.69%
on 10/31/22
+0.89 (+17.87%)
since 08/08/22
52-Week
2.80 +109.64%
on 05/12/22
8.97 -34.56%
on 11/15/21
-2.93 (-33.30%)
since 11/08/21

Most Recent Stories

More News
SHAREHOLDER ALERT: Weiss Law Reminds SBTX, RMED, RCOR, and BTRS Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

SBTX : 5.87 (+1.03%)
RMED : 3.17 (+29.39%)
RCOR : 3.20 (+4.92%)
BTRS : 9.47 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SBTX, POSH, PBFX, RNWK, AERI

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

SBTX : 5.87 (+1.03%)
POSH : 17.82 (-0.06%)
PBFX : 19.90 (-2.40%)
RNWK : 0.7235 (+0.07%)
AERI : 15.25 (+0.07%)
Silverback Therapeutics, Inc. announces the FDA’s acceptance of ARS Pharmaceuticals’ NDA for neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (type I) including Anaphylaxis

Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review ARS Pharmaceuticals, Inc.’s (ARS Pharma) New Drug...

SBTX : 5.87 (+1.03%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMRA, SBTX, COWN, JVA, HVBC

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

IMRA : 4.15 (-2.58%)
SBTX : 5.87 (+1.03%)
COWN : 38.59 (-0.18%)
JVA : 2.37 (+0.42%)
HVBC : 26.64 (-0.04%)
SILVERBACK THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Silverback Therapeutics, Inc. - SBTX

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Silverback Therapeutics, Inc. (the “Company”)...

SBTX : 5.87 (+1.03%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FBMS, SBTX, RFP, COWN

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

FBMS : 34.22 (+0.09%)
SBTX : 5.87 (+1.03%)
RFP : 21.09 (-0.05%)
COWN : 38.59 (-0.18%)
SHAREHOLDER ALERT: Weiss Law Reminds MNRL, ECOM, SBTX, and IRBT Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

MNRL : 35.93 (+1.41%)
ECOM : 23.09 (+0.04%)
SBTX : 5.87 (+1.03%)
IRBT : 52.27 (+0.35%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TMX, VIVO, RFP, SBTX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

TMX : 37.87 (-0.50%)
VIVO : 31.99 (-0.03%)
RFP : 21.09 (-0.05%)
SBTX : 5.87 (+1.03%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SMBC, RFP, SBTX, ZY, PING

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

SMBC : 51.79 (-0.13%)
RFP : 21.09 (-0.05%)
SBTX : 5.87 (+1.03%)
ZY : 2.43 (+1.67%)
PING : 28.50 (+0.11%)
SHAREHOLDER ALERT: Weiss Law Reminds MNRL, ECOM, SBTX, and IRBT Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

MNRL : 35.93 (+1.41%)
ECOM : 23.09 (+0.04%)
SBTX : 5.87 (+1.03%)
IRBT : 52.27 (+0.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Silverback Therapeutics Inc. is a clinical-stage biopharmaceutical company. Its ImmunoTAC technology platform, develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections and other serious diseases. Silverback Therapeutics Inc. is based in Seattle,...

See More

Key Turning Points

3rd Resistance Point 6.54
2nd Resistance Point 6.34
1st Resistance Point 6.11
Last Price 5.87
1st Support Level 5.68
2nd Support Level 5.48
3rd Support Level 5.25

See More

52-Week High 8.97
Fibonacci 61.8% 6.61
Fibonacci 50% 5.89
Last Price 5.87
Fibonacci 38.2% 5.16
52-Week Low 2.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar